Bacterial strains augment cancer therapeutics

被引：3
|
作者：
Hall, Lindsay J. [1 ,2 ,3 ]
Robinson, Stephen D. [1 ,4 ]
机构：
[1] Quadram Inst Biosci, Gut Microbes & Hlth, Norwich Res Pk, Norwich, Norfolk, England
[2] Tech Univ Munich, Sch Life Sci, ZIEL Inst Food & Hlth, Chair Intestinal Microbiome, Freising Weihenstephan, Germany
[3] Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich, Norfolk, England
[4] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England
来源：
NATURE MICROBIOLOGY | 2021年 / 6卷 / 03期
基金：
英国生物技术与生命科学研究理事会;
关键词：
D O I：
10.1038/s41564-021-00871-6
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Bifidobacterium bifidum is enriched in the gut microbiome of patients who respond to cancer treatment, but only selected strains of commercial B. bifidum reduced tumour burden synergistically with therapy in a mouse model.
引用
收藏
页码：275 / 276
页数：2
相关论文
共 50 条
  • [41] Biomarkers in cancer therapeutics
    LoBuglio, AF
    Pluda, J
    Ivy, P
    BIOMARKERS AND SURROGATE ENDPOINTS: CLINICAL RESEARCH AND APPLICATIONS, 2000, 1205 : 233 - 254
  • [42] Proteogenomic profiling of the bacterial strains
    Govorun, V.
    Ilina, E.
    Vereshchagin, V.
    Malkhova, M.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S237 - S237
  • [43] PLASMID LOSS IN BACTERIAL STRAINS
    ESTY, WW
    MILLER, RV
    SANDS, DC
    BIOMETRICS, 1984, 40 (04) : 1204 - 1205
  • [44] Parvoviruses as cancer therapeutics
    Rommelaere, Jean
    HUMAN GENE THERAPY, 2009, 20 (11) : 1353 - 1353
  • [45] Principles and therapeutics of cancer
    Lee, Yoontae
    MOLECULES AND CELLS, 2025, 48 (05)
  • [46] Telomerase and cancer therapeutics
    Harley, Calvin B.
    NATURE REVIEWS CANCER, 2008, 8 (03) : 167 - 179
  • [47] IMMUNOSUPPRESSION IN CANCER THERAPEUTICS
    MIHICH, E
    TRANSPLANTATION PROCEEDINGS, 1975, 7 (02) : 275 - 278
  • [48] MicroRNAs and Cancer Therapeutics
    Man Lung Yeung
    Kuan-Teh Jeang
    Pharmaceutical Research, 2011, 28 : 3043 - 3049
  • [49] Antibody Therapeutics in Cancer
    Sliwkowski, Mark X.
    Mellman, Ira
    SCIENCE, 2013, 341 (6151) : 1192 - 1198
  • [50] Advances in Cancer Therapeutics
    Sparreboom, A.
    Verweij, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (02) : 113 - 117
12345